BACKGROUND: People with prediabetes are at increased risk for developing type 2 diabetes mellitus. Weight reduction through lifestyle modification can significantly reduce diabetes risk. Yet, weight loss varies among individuals and some people do not achieve clinically meaningful weight loss after treatment. OBJECTIVE: Our aim was to evaluate the time point and threshold for achieving ≥5% weight loss after completion of a 16-week worksite, lifestyle intervention for diabetes prevention. DESIGN:Weight change before and after the behavioral intervention among participants randomized to the experimental group was examined. PARTICIPANTS/ SETTING: Individuals with prediabetes aged 18 to 65 years with a body mass index (calculated as kg/m(2)) of 25 to 50 at Ohio State University were eligible. INTERVENTION: The 16-week, group-based intervention, adapted from the Diabetes Prevention Program, was delivered to 32 participants in the experimental group. MAIN OUTCOME MEASURES: Percent weight loss was assessed weekly during the intervention and at 4- and 7-month follow-up. STATISTICAL ANALYSES PERFORMED: Linear regression modeled the relationship between percent weight loss during month 1 of the intervention and percent weight loss at 4 and 7 months. Logistic regression modeled failure to lose ≥5% weight loss at 4 and 7 months using weekly weight change during the first month of intervention. RESULTS:Percent weight loss at intervention week 5 was significantly associated with percent weight loss at 4 and 7 months (all P<0.001). Only 11.1% and 12.5% of participants who failed to achieve a 2.5% weight-loss threshold during month 1 achieved ≥5% weight loss at months 4 and 7, respectively. CONCLUSIONS: The first month of lifestyle treatment is a critical period for helping participants achieve weight loss. Otherwise, individuals who fail to achieve at least 2.5% weight loss may benefit from more intensive rescue efforts or stepped-care interventions.
RCT Entities:
BACKGROUND:People with prediabetes are at increased risk for developing type 2 diabetes mellitus. Weight reduction through lifestyle modification can significantly reduce diabetes risk. Yet, weight loss varies among individuals and some people do not achieve clinically meaningful weight loss after treatment. OBJECTIVE: Our aim was to evaluate the time point and threshold for achieving ≥5% weight loss after completion of a 16-week worksite, lifestyle intervention for diabetes prevention. DESIGN: Weight change before and after the behavioral intervention among participants randomized to the experimental group was examined. PARTICIPANTS/ SETTING: Individuals with prediabetes aged 18 to 65 years with a body mass index (calculated as kg/m(2)) of 25 to 50 at Ohio State University were eligible. INTERVENTION: The 16-week, group-based intervention, adapted from the Diabetes Prevention Program, was delivered to 32 participants in the experimental group. MAIN OUTCOME MEASURES: Percent weight loss was assessed weekly during the intervention and at 4- and 7-month follow-up. STATISTICAL ANALYSES PERFORMED: Linear regression modeled the relationship between percent weight loss during month 1 of the intervention and percent weight loss at 4 and 7 months. Logistic regression modeled failure to lose ≥5% weight loss at 4 and 7 months using weekly weight change during the first month of intervention. RESULTS: Percent weight loss at intervention week 5 was significantly associated with percent weight loss at 4 and 7 months (all P<0.001). Only 11.1% and 12.5% of participants who failed to achieve a 2.5% weight-loss threshold during month 1 achieved ≥5% weight loss at months 4 and 7, respectively. CONCLUSIONS: The first month of lifestyle treatment is a critical period for helping participants achieve weight loss. Otherwise, individuals who fail to achieve at least 2.5% weight loss may benefit from more intensive rescue efforts or stepped-care interventions.
Authors: Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: T A Wadden; G D Foster; J Wang; R N Pierson; M U Yang; K Moreland; A J Stunkard; T B VanItallie Journal: Am J Clin Nutr Date: 1992-07 Impact factor: 7.045
Authors: Jun Ma; Veronica Yank; Lan Xiao; Philip W Lavori; Sandra R Wilson; Lisa G Rosas; Randall S Stafford Journal: JAMA Intern Med Date: 2013-01-28 Impact factor: 21.873
Authors: Krista Casazza; Kevin R Fontaine; Arne Astrup; Leann L Birch; Andrew W Brown; Michelle M Bohan Brown; Nefertiti Durant; Gareth Dutton; E Michael Foster; Steven B Heymsfield; Kerry McIver; Tapan Mehta; Nir Menachemi; P K Newby; Russell Pate; Barbara J Rolls; Bisakha Sen; Daniel L Smith; Diana M Thomas; David B Allison Journal: N Engl J Med Date: 2013-01-31 Impact factor: 91.245
Authors: Jessica L Unick; Daniel Beavers; John M Jakicic; Abbas E Kitabchi; William C Knowler; Thomas A Wadden; Rena R Wing Journal: Diabetes Care Date: 2011-08-11 Impact factor: 19.112
Authors: Jessica L Unick; Patricia E Hogan; Rebecca H Neiberg; Lawrence J Cheskin; Gareth R Dutton; Gina Evans-Hudnall; Robert Jeffery; Abbas E Kitabchi; Julie A Nelson; F Xavier Pi-Sunyer; Delia Smith West; Rena R Wing Journal: Obesity (Silver Spring) Date: 2014-04-28 Impact factor: 5.002
Authors: Jena Shaw Tronieri; Thomas A Wadden; Ariana M Chao; Rebecca L Pearl; Naji Alamuddin; Robert I Berkowitz Journal: Ann Behav Med Date: 2019-03-01
Authors: Yvonne L Eaglehouse; Elizabeth M Venditti; M Kaye Kramer; Vincent C Arena; Karl K Vanderwood; Bonny Rockette-Wagner; Andrea M Kriska Journal: Transl Behav Med Date: 2017-12 Impact factor: 3.046
Authors: Nancy E Sherwood; A Lauren Crain; Elisabeth M Seburg; Meghan L Butryn; Evan M Forman; Melissa M Crane; Rona L Levy; Alicia S Kunin-Batson; Robert W Jeffery Journal: Ann Behav Med Date: 2022-03-01
Authors: Nan Lv; Lan Xiao; Lisa G Rosas; Elizabeth M Venditti; Joshua M Smyth; Megan A Lewis; Mark B Snowden; Corina R Ronneberg; Leanne M Williams; Ben S Gerber; Olusola A Ajilore; Aashutos S Patel; Jun Ma Journal: Ann Behav Med Date: 2021-11-18